Literature DB >> 1595392

Immunocytochemical study of progesterone receptor in human meningioma.

M Perrot-Applanat1, M T Groyer-Picard, M Kujas.   

Abstract

Progesterone (PR) and oestrogen (ER) receptors were examined in meningiomas from 36 patients, using immunocytochemistry. The present experiments were performed to evaluate: (a) the presence and intracellular localization of these receptors, (b) whether PR immunostaining can be correlated (or not) with proliferation potential, as evaluated by histopathological features or the clinical evolution of this neuropathological tumour. Twenty six tumours (72%) tested were positive for PR but none for ER. The presence of PR immunostaining was more frequently observed in females (79% versus 58% in males) and premenopausal status (84% versus 3/5 in postmenopausal). Correlations of PR immunostaining with the histologic type showed 89% of meningothelial, 4/6 cases of transitional, 1/3 case of fibroblastic and 1/4 cases of anaplastic meningiomas to be immunostained for PR. Staining was confined to tumours arachnoidal cells. A heterogeneous distribution was observed in most PR-positive meningiomas. The preferential immunostaining in meningothelial histological types correlates with the presence of PR in normal arachnoidal cells. The proliferating potential of these meningiomas was evaluated by the immunostaining of an antigen only present in proliferating cells (Ki antigen). There was no significant correlation between PR status and the Ki labelling rate, or rapid clinical evolution. These data were compared with those previously reported. They confirm that the cellular biosynthesis of PR in meningiomas is not oestrogen regulated as it is in other sex steroid tissues, such as the breast and the endometrium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1595392     DOI: 10.1007/bf01400586

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  37 in total

1.  The recurrence of intracranial meningiomas after surgical treatment.

Authors:  D SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

2.  The relapsing course of certain meningiomas in relation to pregnancy and menstruation.

Authors:  E R BICKERSTAFF; J M SMALL; I A GUEST
Journal:  J Neurol Neurosurg Psychiatry       Date:  1958-05       Impact factor: 10.154

3.  Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level.

Authors:  D Ploton; M Menager; P Jeannesson; G Himber; F Pigeon; J J Adnet
Journal:  Histochem J       Date:  1986-01

4.  Regulation and localization of estrogen and progestin receptors in the pituitary of steroid-treated monkeys.

Authors:  S A Sprangers; N B West; R M Brenner; C L Bethea
Journal:  Endocrinology       Date:  1990-02       Impact factor: 4.736

5.  A rapid method of epitope mapping. Application to the study of immunogenic domains and to the characterization of various forms of rabbit progesterone receptor.

Authors:  F Lorenzo; A Jolivet; H Loosfelt; M Thu vu Hai; S Brailly; M Perrot-Applanat; E Milgrom
Journal:  Eur J Biochem       Date:  1988-09-01

6.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

Review 7.  Dynamics of steroid hormone receptor action.

Authors:  B S Katzenellenbogen
Journal:  Annu Rev Physiol       Date:  1980       Impact factor: 19.318

8.  Estrogen-receptor protein in intracranial meningiomas.

Authors:  M S Donnell; G A Meyer; W L Donegan
Journal:  J Neurosurg       Date:  1979-04       Impact factor: 5.115

9.  Estrogen and progesterone receptors in meningiomas in relation to clinical and pathologic features.

Authors:  T M Markwalder; D T Zava; A Goldhirsch; R V Markwalder
Journal:  Surg Neurol       Date:  1983-07

10.  Estrogen-inducible progesterone receptor in primary cultures of rat glial cells.

Authors:  I Jung-Testas; J M Renoir; J M Gasc; E E Baulieu
Journal:  Exp Cell Res       Date:  1991-03       Impact factor: 3.905

View more
  11 in total

1.  Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.

Authors:  Ankur R Sangoi; Mohanpal S Dulai; Andrew H Beck; Daniel J Brat; Hannes Vogel
Journal:  Am J Surg Pathol       Date:  2009-05       Impact factor: 6.394

2.  Expression of the c-erbB-2-encoded oncoprotein and progesterone receptor in human meningiomas.

Authors:  J Schlegel; B Ullrich; G Stumm; P Gass; I M Harwerth; N E Hynes; M Kiessling
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

3.  Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors.

Authors:  Michael S Dirks; John A Butman; H Jeffrey Kim; Tianxia Wu; Keaton Morgan; Anne P Tran; Russell R Lonser; Ashok R Asthagiri
Journal:  J Neurosurg       Date:  2012-04-13       Impact factor: 5.115

4.  Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression.

Authors:  Katariina Korhonen; Tiina Salminen; Jani Raitanen; Anssi Auvinen; Jorma Isola; Hannu Haapasalo
Journal:  J Neurooncol       Date:  2006-05-13       Impact factor: 4.130

Review 5.  The biology of meningiomas.

Authors:  I E McCutcheon
Journal:  J Neurooncol       Date:  1996-09       Impact factor: 4.130

6.  The prognostic value of progesterone receptor status in meningiomas.

Authors:  F Roser; M Nakamura; M Bellinzona; S K Rosahl; H Ostertag; M Samii
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

7.  High sensitivity of the in vivo detection of somatostatin receptors by 111indium (DTPA-octreotide)-scintigraphy in meningioma patients.

Authors:  G Hildebrandt; K Scheidhauer; C Luyken; H Schicha; N Klug; P Dahms; B Krisch
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

8.  Progestin receptors in meningiomas. Comparison of cytosolic assays with immunocytochemical identification in cryostat and paraffin sections.

Authors:  G Blaauw; J Koudstaal; M A Blankenstein; M Debets-Te Baerts; A H Gijzen
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

9.  Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature.

Authors:  Stefan Wolfsberger; Soroush Doostkam; Hans-Gerd Boecher-Schwarz; Karl Roessler; Michael van Trotsenburg; Johannes A Hainfellner; Engelbert Knosp
Journal:  Neurosurg Rev       Date:  2004-05-27       Impact factor: 3.042

10.  Relationships Between Neurofibromatosis-2, Progesterone Receptor Expression, the Use of Exogenous Progesterone, and Risk of Orbitocranial Meningioma in Females.

Authors:  Agus Supartoto; Muhammad Bayu Sasongko; Datu Respatika; Indra Tri Mahayana; Suhardjo Pawiroranu; Hari Kusnanto; Dhimas Hari Sakti; Prima Sugesty Nurlaila; Didik Setyo Heriyanto; Sofia Mubarika Haryana
Journal:  Front Oncol       Date:  2019-01-09       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.